Arthralgias in Children: What to Do When Kids Present with Joint Pain
Emerging Treatments for OA: New Therapies Target Joint Pain, Not Just Structural Damage
Cerebral Blood Flow Variability May Provide Insights into Fibromyalgia
FDA Approves Opioid Treatment
5-Year Data on Secukinumab in AS; Oliceridine Not Recommended for FDA Approval
Mirtazapine Ineffective for Fibromyalgia
Central Sensitization to Pain May Not Predict Long-Term Outcomes after Carpal Tunnel Release Surgery
Revised Application Expected for IV Meloxicam; Plus EU Approves Tildrakizumab
Pain Response to Low Intensity Pressure Tied to Cognitive Deficits in Fibromyalgia
- 1
- 2
- 3
- …
- 24
- Next Page »